Giant Ovarian Tumor: A Case Report and Review of the Literature
Amine Maazouz *
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Yosra Asatach
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Mohammed Lamghari
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Maroua Sabur Kadhem
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Imad El-Azzaoui
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Hind Habladje
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Mohammed Najih
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Hakim El-Kaoui
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Sidi Mohamed Bouchentouf
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Ahmed Bounaim
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
Mountassir Moujahid
Department of Visceral Surgery 1, Faculty of Medicine and Pharmacy, Mohammed V Military Hospital, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Epithelial ovarian cancer is the most lethal gynecological cancer. Serous-type epithelial ovarian cancer, the most common form with more than 50% of cases, is often diagnosed late and associated with a poor prognosis.
This is a retrospective study on a patient who was diagnosed with a clinically benign giant ovarian tumor and who was hospitalized in the visceral surgery department "I" at the Mohamed V Military Instruction Hospital in Rabat.
The surgical intervention allowed complete excision of the mass (R0 resection). Likewise, we performed a hysterectomy, bilateral adnexectomy, omentectomy and appendectomy without lymph node dissection.
Histological examination was compatible with a morphological appearance and an immunohistochemical profile in favor of a high-grade serous ovarian carcinoma.
Adjuvant chemotherapy type treatment based on PACLITAXEL 280 CARBOPLATINE 650 spread over 6 cycles.
The evolution was favorable in our patient, with a follow-up of one year without any sign of recurrence.
Keywords: Ovary, ovarian giant mass, Serous carcinoma